FASN and neoplasm: Table 6 describes the altered signaling pathways and how MET decreases tumor growth, volume, and cell proliferation, increasing cell death and model survival. It increases p-AMPK and active Caspase-3 and decreases Ki-67 and fatty acid synthase (FASN) [18,33,47].